{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:56:28Z","timestamp":1787954188777,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00108-023-01526-w","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T14:04:36Z","timestamp":1684850676000},"page":"525-531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sarkopenie bei chronischen Lebererkrankungen","Sarcopenia in chronic liver diseases"],"prefix":"10.1007","volume":"64","author":[{"given":"Monika","family":"Rau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"issue":"1","key":"1526_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft\u00a0AJ, Bahat\u00a0G, Bauer\u00a0J, Boirie\u00a0Y, Bruy\u00e8re\u00a0O, Cederholm\u00a0T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"issue":"2","key":"1526_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","volume":"38","author":"M Plauth","year":"2019","unstructured":"Plauth\u00a0M, Bernal\u00a0W, Dasarathy\u00a0S, Merli\u00a0M, Plank\u00a0LD, Sch\u00fctz\u00a0T et\u00a0al (2019) ESPEN guideline on clinical nutrition in liver disease. Clin Nutr 38(2):485\u2013521. https:\/\/doi.org\/10.1016\/j.clnu.2018.12.022","journal-title":"Clin Nutr"},{"issue":"1","key":"1526_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","volume":"38","author":"T Cederholm","year":"2019","unstructured":"Cederholm\u00a0T, Jensen\u00a0GL, Correia\u00a0M, Gonzalez\u00a0MC, Fukushima\u00a0R, Higashiguchi\u00a0T et\u00a0al (2019) GLIM criteria for the diagnosis of malnutrition\u2014A consensus report from the global clinical nutrition community. Clin Nutr 38(1):1\u20139. https:\/\/doi.org\/10.1016\/j.clnu.2018.08.002","journal-title":"Clin Nutr"},{"issue":"6","key":"1526_CR4","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.clnu.2022.02.001","volume":"41","author":"R Barazzoni","year":"2022","unstructured":"Barazzoni\u00a0R, Jensen\u00a0GL, Correia\u00a0M, Gonzalez\u00a0MC, Higashiguchi\u00a0T, Shi\u00a0HP et\u00a0al (2022) Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition (GLIM) diagnosis of malnutrition. Clin Nutr 41(6):1425\u20131433. https:\/\/doi.org\/10.1016\/j.clnu.2022.02.001","journal-title":"Clin Nutr"},{"issue":"3","key":"1526_CR5","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","volume":"69","author":"L Pimpin","year":"2018","unstructured":"Pimpin\u00a0L, Cortez-Pinto\u00a0H, Negro\u00a0F, Corbould\u00a0E, Lazarus\u00a0JV, Webber\u00a0L et al (2018) Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. J\u00a0Hepatol 69(3):718\u2013735. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.011","journal-title":"J Hepatol"},{"issue":"3","key":"1526_CR6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jhep.2021.11.006","volume":"76","author":"X Tantai","year":"2022","unstructured":"Tantai\u00a0X, Liu\u00a0Y, Yeo\u00a0YH, Praktiknjo\u00a0M, Mauro\u00a0E, Hamaguchi\u00a0Y et al (2022) Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis. J\u00a0Hepatol 76(3):588\u2013599. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.006","journal-title":"J Hepatol"},{"issue":"4","key":"1526_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.51821\/85.4.10899","volume":"85","author":"G Henin","year":"2022","unstructured":"Henin\u00a0G, Lanthier\u00a0N, Dahlqvist\u00a0G (2022) Pathophysiological changes of the liver-muscle axis in end-stage liver disease: what is the right target? Acta Gastroenterol Belg 85(4):611\u2013624. https:\/\/doi.org\/10.51821\/85.4.10899","journal-title":"Acta Gastroenterol Belg"},{"issue":"1","key":"1526_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","volume":"70","author":"M Merli","year":"2019","unstructured":"Merli M, Berzigotti A, Zelber-Sagi S, Dasarathy S, Montagnese S, Genton L, Plauth M, Par\u00e9s A (2019) EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J\u00a0Hepatol 70(1):172\u2013193. https:\/\/doi.org\/10.1016\/j.jhep.2018.06.024","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"1526_CR9","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jhep.2017.11.030","volume":"68","author":"JLA van Vugt","year":"2018","unstructured":"van Vugt\u00a0JLA, Alferink\u00a0LJM, Buettner\u00a0S, Gaspersz\u00a0MP, Bot\u00a0D, Darwish\u00a0MS et\u00a0al (2018) A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a\u00a0national cohort. J\u00a0Hepatol 68(4):707\u2013714. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.030","journal-title":"J Hepatol"},{"issue":"1","key":"1526_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jceh.2022.06.005","volume":"13","author":"WER Ii","year":"2023","unstructured":"Ii\u00a0WER, Satapathy\u00a0SK (2023) Sarcopenia in the cirrhotic patient: current knowledge and future directions. J\u00a0Clin Exp Hepatol 13(1):162\u2013177. https:\/\/doi.org\/10.1016\/j.jceh.2022.06.005","journal-title":"J Clin Exp Hepatol"},{"issue":"7","key":"1526_CR11","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1038\/ctg.2015.31","volume":"6","author":"AJ Montano-Loza","year":"2015","unstructured":"Montano-Loza\u00a0AJ, Duarte-Rojo\u00a0A, Meza-Junco\u00a0J, Baracos\u00a0VE, Sawyer\u00a0MB, Pang\u00a0JX et al (2015) Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol 6(7):e102. https:\/\/doi.org\/10.1038\/ctg.2015.31","journal-title":"Clin Transl Gastroenterol"},{"key":"1526_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081345","author":"M Ebadi","year":"2022","unstructured":"Ebadi\u00a0M, Tsien\u00a0C, Bhanji\u00a0RA, Dunichand-Hoedl\u00a0AR, Rider\u00a0E, Motamedrad\u00a0M et al (2022) Skeletal muscle pathological fat infiltration (Myosteatosis) is associated with higher mortality in patients with cirrhosis. Cells. https:\/\/doi.org\/10.3390\/cells11081345","journal-title":"Cells"},{"issue":"2","key":"1526_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/hep.22367","volume":"48","author":"LD Plank","year":"2008","unstructured":"Plank\u00a0LD, Gane\u00a0EJ, Peng\u00a0S, Muthu\u00a0C, Mathur\u00a0S, Gillanders\u00a0L et al (2008) Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a\u00a0randomized 12-month trial. Hepatology 48(2):557\u2013566. https:\/\/doi.org\/10.1002\/hep.22367","journal-title":"Hepatology"},{"issue":"6","key":"1526_CR14","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jhep.2016.07.040","volume":"65","author":"S Dasarathy","year":"2016","unstructured":"Dasarathy\u00a0S, Merli\u00a0M (2016) Sarcopenia from mechanism to diagnosis and treatment in liver disease. J\u00a0Hepatol 65(6):1232\u20131244. https:\/\/doi.org\/10.1016\/j.jhep.2016.07.040","journal-title":"J Hepatol"},{"issue":"6","key":"1526_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1159\/000491015","volume":"36","author":"X Pan","year":"2018","unstructured":"Pan\u00a0X, Han\u00a0Y, Zou\u00a0T, Zhu\u00a0G, Xu\u00a0K, Zheng\u00a0J et al (2018) Sarcopenia contributes to the progression of nonalcoholic fatty liver disease-related fibrosis: a meta-analysis. Dig Dis 36(6):427\u2013436. https:\/\/doi.org\/10.1159\/000491015","journal-title":"Dig Dis"},{"issue":"1","key":"1526_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","volume":"66","author":"BK Koo","year":"2017","unstructured":"Koo\u00a0BK, Kim\u00a0D, Joo\u00a0SK, Kim\u00a0JH, Chang\u00a0MS, Kim\u00a0BG et al (2017) Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J\u00a0Hepatol 66(1):123\u2013131. https:\/\/doi.org\/10.1016\/j.jhep.2016.08.019","journal-title":"J Hepatol"},{"key":"1526_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103519","author":"H Nishikawa","year":"2021","unstructured":"Nishikawa\u00a0H, Asai\u00a0A, Fukunishi\u00a0S, Nishiguchi\u00a0S, Higuchi\u00a0K (2021) Metabolic Syndrome and Sarcopenia. Nutrients. https:\/\/doi.org\/10.3390\/nu13103519","journal-title":"Nutrients"},{"key":"1526_CR18","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0358","author":"SK Joo","year":"2022","unstructured":"Joo\u00a0SK, Kim\u00a0W (2022) Interaction between Sarcopenia and NAFLD. Clin Mol Hepatol. https:\/\/doi.org\/10.3350\/cmh.2022.0358","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"1526_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jcsm.12048","volume":"7","author":"TK Malmstrom","year":"2016","unstructured":"Malmstrom\u00a0TK, Miller\u00a0DK, Simonsick\u00a0EM, Ferrucci\u00a0L, Morley\u00a0JE (2016) SARC-F: a\u00a0symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J\u00a0Cachexia Sarcopenia Muscle 7(1):28\u201336. https:\/\/doi.org\/10.1002\/jcsm.12048","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"1526_CR20","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.clnu.2021.11.014","volume":"41","author":"LM Donini","year":"2022","unstructured":"Donini\u00a0LM, Busetto\u00a0L, Bischoff\u00a0SC, Cederholm\u00a0T, Ballesteros-Pomar\u00a0MD, Batsis\u00a0JA et al (2022) Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin Nutr 41(4):990\u20131000. https:\/\/doi.org\/10.1016\/j.clnu.2021.11.014","journal-title":"Clin Nutr"},{"key":"1526_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18227","author":"JM Guralnik","year":"2023","unstructured":"Guralnik\u00a0JM, Cawthon\u00a0PM, Bhasin\u00a0S, Fielding\u00a0R, Magaziner\u00a0J, Cruz-Jentoft\u00a0AJ et al (2023) Limited physician knowledge of sarcopenia: A survey. J\u00a0Am Geriatr Soc. https:\/\/doi.org\/10.1111\/jgs.18227","journal-title":"J Am Geriatr Soc"},{"key":"1526_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.clnesp.2022.02.013","volume":"48","author":"B Chapman","year":"2022","unstructured":"Chapman\u00a0B, Goh\u00a0SK, Parker\u00a0F, Romero\u00a0S, Sinclair\u00a0M, Gow\u00a0P et\u00a0al (2022) Malnutrition and low muscle strength are independent predictors of clinical outcomes and healthcare costs after liver transplant. Clin Nutr ESPEN 48:210\u2013219. https:\/\/doi.org\/10.1016\/j.clnesp.2022.02.013","journal-title":"Clin Nutr ESPEN"},{"issue":"6","key":"1526_CR23","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/hep4.1688","volume":"5","author":"FR Williams","year":"2021","unstructured":"Williams\u00a0FR, Milliken\u00a0D, Lai\u00a0JC, Armstrong\u00a0MJ (2021) Assessment of the frail patient with end-stage liver disease: a practical overview of sarcopenia, physical function, and disability. Hepatol Commun 5(6):923\u2013937. https:\/\/doi.org\/10.1002\/hep4.1688","journal-title":"Hepatol Commun"},{"issue":"2","key":"1526_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cgh.2011.08.028","volume":"10","author":"AJ Montano-Loza","year":"2012","unstructured":"Montano-Loza\u00a0AJ, Meza-Junco\u00a0J, Prado\u00a0CM, Lieffers\u00a0JR, Baracos\u00a0VE, Bain\u00a0VG et al (2012) Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 10(2):166\u2013173. https:\/\/doi.org\/10.1016\/j.cgh.2011.08.028","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"1526_CR25","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/jcsm.12349","volume":"9","author":"M Ebadi","year":"2018","unstructured":"Ebadi\u00a0M, Wang\u00a0CW, Lai\u00a0JC, Dasarathy\u00a0S, Kappus\u00a0MR, Dunn\u00a0MA et\u00a0al (2018) Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis. J\u00a0Cachexia Sarcopenia Muscle 9(6):1053\u20131062. https:\/\/doi.org\/10.1002\/jcsm.12349","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"1526_CR26","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.29602","volume":"67","author":"M Praktiknjo","year":"2018","unstructured":"Praktiknjo\u00a0M, Book\u00a0M, Luetkens\u00a0J, Pohlmann\u00a0A, Meyer\u00a0C, Thomas\u00a0D et al (2018) Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology 67(3):1014\u20131026. https:\/\/doi.org\/10.1002\/hep.29602","journal-title":"Hepatology"},{"key":"1526_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/nu14091780","author":"M Plauth","year":"2022","unstructured":"Plauth\u00a0M, Sulz\u00a0I, Viertel\u00a0M, H\u00f6fer\u00a0V, Witt\u00a0M, Raddatz\u00a0F et al (2022) Phase angle is a\u00a0stronger predictor of hospital outcome than subjective global assessment-results from the prospective Dessau hospital malnutrition study. Nutrients. https:\/\/doi.org\/10.3390\/nu14091780","journal-title":"Nutrients"},{"issue":"6","key":"1526_CR28","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/hep.32268","volume":"75","author":"JC Lai","year":"2022","unstructured":"Lai\u00a0JC, Shui\u00a0AM, Duarte-Rojo\u00a0A, Ganger\u00a0DR, Rahimi\u00a0RS, Huang\u00a0CY et al (2022) Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. Hepatology 75(6):1471\u20131479. https:\/\/doi.org\/10.1002\/hep.32268","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"1526_CR29","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/j.jhep.2021.01.025","volume":"75","author":"P Tandon","year":"2021","unstructured":"Tandon\u00a0P, Montano-Loza\u00a0AJ, Lai\u00a0JC, Dasarathy\u00a0S, Merli\u00a0M (2021) Sarcopenia and frailty in decompensated cirrhosis. J\u00a0Hepatol 75(Suppl 1):S147\u2013s62. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.025","journal-title":"J Hepatol"},{"issue":"6","key":"1526_CR30","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s41999-022-00706-5","volume":"13","author":"PM Cawthon","year":"2022","unstructured":"Cawthon\u00a0PM, Visser\u00a0M, Arai\u00a0H, \u00c1vila-Funes\u00a0JA, Barazzoni\u00a0R, Bhasin\u00a0S et al (2022) Defining terms commonly used in sarcopenia research: a\u00a0glossary proposed by the Global Leadership in Sarcopenia (GLIS) Steering Committee. Eur Geriatr Med 13(6):1239\u20131244. https:\/\/doi.org\/10.1007\/s41999-022-00706-5","journal-title":"Eur Geriatr Med"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01526-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-023-01526-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01526-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T12:02:38Z","timestamp":1685620958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-023-01526-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1526"],"URL":"https:\/\/doi.org\/10.1007\/s00108-023-01526-w","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"25 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Rau gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von der Autorin keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}